HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.
about
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications.
P2860
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@en
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@nl
type
label
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@en
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@nl
prefLabel
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@en
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@nl
P2860
P50
P356
P1476
HIV-1 Coinfection Does Not Red ...... ican Tuberculosis Outpatients.
@en
P2860
P304
P356
10.1128/AAC.00480-16
P407
P50
P577
2016-08-01T00:00:00Z